SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-056232
Filing Date
2024-05-09
Accepted
2024-05-09 06:46:09
Documents
51
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nuvl-20240331.htm   iXBRL 10-Q 1744842
2 EX-10.1 nuvl-ex10_1.htm EX-10.1 24666
3 EX-31.1 nuvl-ex31_1.htm EX-31.1 15817
4 EX-31.2 nuvl-ex31_2.htm EX-31.2 15826
5 EX-32.1 nuvl-ex32_1.htm EX-32.1 9447
6 EX-32.2 nuvl-ex32_2.htm EX-32.2 8217
7 GRAPHIC img240553393_0.jpg GRAPHIC 173738
  Complete submission text file 0000950170-24-056232.txt   5831783

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT nuvl-20240331.xsd EX-101.SCH 740233
55 EXTRACTED XBRL INSTANCE DOCUMENT nuvl-20240331_htm.xml XML 733968
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40671 | Film No.: 24928435
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)